Delivery Order SPE2DB25D3003-SPE2DB25FPXBS
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,413.54 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Vyvanse 30 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,946.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on September 18, 2025, with completion scheduled for September 19, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,437.80 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $1,783.60 for 100 capsules of Vyvanse 20 mg, with an ultimate completion date of June 2, 2025. This non-set-aside competitive award was issued on May 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the...
- The Defense Logistics Agency awarded a $1,269.13 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,769.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical products will be delivered to...
- The Defense Logistics Agency's Medical Supply Chain awarded a $17,094.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Vyvanse capsules 50mg, with completion targeted for September 15, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a...
- The Defense Logistics Agency awarded a delivery order valued at $14,112.20 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 50 mg capsules (100-count units). This competitively awarded, firm fixed-price contract is scheduled for ultimate completion by August 18, 2025, with performance conducted at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Vyvanse 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $7,471.25. This non-set-aside competitive award represents a continuation of pharmaceutical supply support to the federal government, with performance based in Conshohocken, Pennsylvania, and completion scheduled for September 10, 2025. The delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $4,698.42. This non-competitive delivery order represents a firm fixed price transaction with a completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...